184 related articles for article (PubMed ID: 30203965)
21. Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.
Pajk S; Knez D; Košak U; Zorović M; Brazzolotto X; Coquelle N; Nachon F; Colletier JP; Živin M; Stojan J; Gobec S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):498-505. PubMed ID: 31914836
[TBL] [Abstract][Full Text] [Related]
22. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
23. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
[TBL] [Abstract][Full Text] [Related]
24. Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
Darvesh S; Reid GA
Chem Biol Interact; 2016 Nov; 259(Pt B):307-312. PubMed ID: 27091549
[TBL] [Abstract][Full Text] [Related]
25. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
Li B; Stribley JA; Ticu A; Xie W; Schopfer LM; Hammond P; Brimijoin S; Hinrichs SH; Lockridge O
J Neurochem; 2000 Sep; 75(3):1320-31. PubMed ID: 10936216
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of Alzheimer's Disease and
Yang Y; Zhang L; Wang J; Cao Y; Li S; Qin W; Liu Y
Anal Chem; 2022 Oct; 94(39):13498-13506. PubMed ID: 36121878
[TBL] [Abstract][Full Text] [Related]
27. Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro.
Jasiecki J; Targońska M; Janaszak-Jasiecka A; Kalinowski L; Waleron K; Wasąg B
Chem Biol Interact; 2023 Dec; 386():110783. PubMed ID: 37884182
[TBL] [Abstract][Full Text] [Related]
28. A far-red/near-infrared fluorescence probe with large Stokes shift for monitoring butyrylcholinesterase (BChE) in living cells and in vivo.
Zhang WD; Zhang JM; Qin CZ; Wang XR; Zhou YB
Anal Chim Acta; 2022 Dec; 1235():340540. PubMed ID: 36368817
[TBL] [Abstract][Full Text] [Related]
29. Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.
Blondet B; Carpentier G; Ferry A; Chatonnet A; Courty J
J Histochem Cytochem; 2010 Dec; 58(12):1075-82. PubMed ID: 20805581
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent Imaging of β-Amyloid Using BODIPY Based Near-Infrared Off-On Fluorescent Probe.
Ren W; Zhang J; Peng C; Xiang H; Chen J; Peng C; Zhu W; Huang R; Zhang H; Hu Y
Bioconjug Chem; 2018 Oct; 29(10):3459-3466. PubMed ID: 30189724
[TBL] [Abstract][Full Text] [Related]
31. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
32. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
33. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
Reid GA; Darvesh S
Chem Biol Interact; 2024 Apr; 395():111012. PubMed ID: 38648920
[TBL] [Abstract][Full Text] [Related]
34. Butyrylcholinesterase attenuates amyloid fibril formation in vitro.
Diamant S; Podoly E; Friedler A; Ligumsky H; Livnah O; Soreq H
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8628-33. PubMed ID: 16731619
[TBL] [Abstract][Full Text] [Related]
35. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
36. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265.
Okamura N; Mori M; Furumoto S; Yoshikawa T; Harada R; Ito S; Fujikawa Y; Arai H; Yanai K; Kudo Y
J Alzheimers Dis; 2011; 23(1):37-48. PubMed ID: 20930313
[TBL] [Abstract][Full Text] [Related]
37. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
[TBL] [Abstract][Full Text] [Related]
38. Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro.
Podoly E; Bruck T; Diamant S; Melamed-Book N; Weiss A; Huang Y; Livnah O; Langermann S; Wilgus H; Soreq H
Neurodegener Dis; 2008; 5(3-4):232-6. PubMed ID: 18322399
[TBL] [Abstract][Full Text] [Related]
39. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]